摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-萘-2-基丁酸 | 15410-83-0

中文名称
2-萘-2-基丁酸
中文别名
——
英文名称
2-(naphthalen-2-yl)butanoic acid
英文别名
alpha-Ethyl-2-naphthaleneacetic acid;2-naphthalen-2-ylbutanoic acid
2-萘-2-基丁酸化学式
CAS
15410-83-0
化学式
C14H14O2
mdl
——
分子量
214.264
InChiKey
BKYOHEHDQWPGOY-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.6
  • 重原子数:
    16
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.21
  • 拓扑面积:
    37.3
  • 氢给体数:
    1
  • 氢受体数:
    2

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2-萘-2-基丁酸氯化亚砜仲丁胺 作用下, 以 四氢呋喃甲苯 为溶剂, 反应 12.0h, 生成 2-naphthyl ethyl ketene
    参考文献:
    名称:
    NHC促进立体异构和化学扩散的芳烷基烯酮与氯的官能化
    摘要:
    用N-杂环卡宾处理烷基芳基烯酮和三氯乙醛(氯代)时,观察到立体和化学发散对映选择性反应途径,选择性地产生β-内酯(高达88:12 dr,高达94%  ee)或α-氯代酯(高达至94%  ee)。乙烯酮中的2-芳基取代或α-支链的i Pr烷基取代基都有利于氯化途径,从而使氯醛可以在不对称催化中用作亲电子氯化试剂。
    DOI:
    10.1002/chem.201503308
  • 作为产物:
    描述:
    2-萘硼酸甲酸 、 palladium diacetate 、 potassium carbonate三苯基膦 作用下, 以 甲苯 为溶剂, 反应 23.0h, 生成 2-萘-2-基丁酸
    参考文献:
    名称:
    Carbonylative Transformation of Allylarenes with CO Surrogates: Tunable Synthesis of 4-Arylbutanoic Acids, 2-Arylbutanoic Acids, and 4-Arylbutanals
    摘要:
    In this Communication, procedures for the selective synthesis of 4-arylbutanoic acids, 2-arylbutanoic acids, and 4-arylbutanals from the same allylbenzenes have been developed. With formic acid or TFBen as the CO surrogate, reactions proceed selectively and effectively under carbon monoxide gas-free conditions.
    DOI:
    10.1021/acs.orglett.9b02047
点击查看最新优质反应信息

文献信息

  • Photoinduced Copper‐Catalyzed Asymmetric Decarboxylative Alkynylation with Terminal Alkynes
    作者:Hai‐Dong Xia、Zhong‐Liang Li、Qiang‐Shuai Gu、Xiao‐Yang Dong、Jia‐Heng Fang、Xuan‐Yi Du、Li‐Lei Wang、Xin‐Yuan Liu
    DOI:10.1002/anie.202006317
    日期:2020.9.21
    photoinduced coppercatalyzed asymmetric radical decarboxylative alkynylation of bench‐stable N‐hydroxyphthalimide(NHP)‐type esters of racemic alkyl carboxylic acids with terminal alkynes, which provides a flexible platform for the construction of chiral C(sp3)−C(sp) bonds. Critical to the success of this process are not only the use of the copper catalyst as a dual photo‐ and crosscoupling catalyst but
    我们描述了外消旋烷基羧酸的N-羟基邻苯二甲酰亚胺(NHP)型酯与末端炔烃的光诱导铜催化不对称自由基脱羧烷基化反应,为手性C的构建提供了灵活的平台(sp 3)-C(sp)键。该方法成功的关键不仅在于将铜催化剂用作光和交联的双重催化剂,而且还需要调整NHP型酯以分别抑制烷基和末端炔烃的均质二聚化。由于使用了稳定且易于获得的NHP型酯,与使用烷基卤化物对应物的反应相比,该反应的底物范围更广,涵盖了(杂)苄基,烯丙基和氨基羰基取代的羧酸衍生物,并且(杂芳基和烷基以及甲硅烷基炔烃,因此为先前报道的方法提供了至关重要的补充方法。
  • Palladium-Catalyzed α-Arylation of Carboxylic Acids and Secondary Amides via a Traceless Protecting Strategy
    作者:Zhi-Tao He、John F. Hartwig
    DOI:10.1021/jacs.9b03291
    日期:2019.7.31
    for the long-standing challenge of conducting the palladium-catalyzed α-arylation of carboxylic aids and secondary amides with aryl halides. Both of the presented coupling processes occur with a variety of carboxylic acids and amides and with a variety of aryl bromides containing a broad range of functional groups, including base-sensitive functionality like acyl, alkoxycarbonyl, nitro, cyano, and even
    针对钯催化羧酸助剂和仲酰胺与芳基卤化物的 α-芳基化这一长期存在的挑战,提出了一种新颖的无痕保护策略。所提出的两种偶联过程均与各种羧酸和酰胺以及各种含有多种官能团的芳基溴发生,包括碱敏感官能团,如酰基、烷氧基羰基、硝基、氰基,甚至羟基。通过该方法一步制备了5种商品化药物,收率81-96%。低钯负载量药物萘普生和氟比洛芬的克级合成进一步凸显了该方法的实用价值。
  • Highly Enantioselective Direct Alkylation of Arylacetic Acids with Chiral Lithium Amides as Traceless Auxiliaries
    作者:Craig E. Stivala、Armen Zakarian
    DOI:10.1021/ja205107x
    日期:2011.8.10
    A direct, highly enantioselective alkylation of arylacetic acids via enediolates using a readily available chiral lithium amide as a stereodirecting reagent has been developed. This approach circumvents the traditional attachment and removal of chiral auxiliaries used currently for this type of transformation. The protocol is operationally simple, and the chiral reagent is readily recoverable.
    已经开发出使用容易获得的手性氨基锂作为立体定向试剂通过烯二醇对芳基乙酸进行直接、高度对映选择性的烷基化。这种方法绕过了目前用于此类转化的手性助剂的传统附着和去除。该方案操作简单,手性试剂易于回收。
  • Optically active α- and β-naphthalene derivatives—IV
    作者:O. Piccolo、R. Menicagli、L. Lardicci
    DOI:10.1016/0040-4020(79)88004-7
    日期:1979.1
    The (S) methyl 3-(α- and β-naphthyl)-butanoates have been related to the optically active title compounds and to 2-(α- and β-naphthyl)-butanoic-, -3-methylbutanoic- and -3,3-dimethylbutanoic acids. The absolute configurations and maximum rotatory powers (this is in fact, all that has been measured, in terms of rotatory power) of the naphthyl hydrocarbons and their related compounds have been established
    3-(α-和β-萘基)-丁酸甲酯(S)与旋光标题化合物以及2-(α-和β-萘基)-丁酸,-3-甲基丁酸和-3有关,3-二甲基丁酸。已经确定了萘基烃及其相关化合物的绝对构型和最大旋转功率(实际上是所有以旋转功率衡量的)。
  • Substituted heterocyclic compounds and methods of use
    申请人:Liu Longbin
    公开号:US20050043301A1
    公开(公告)日:2005-02-24
    The present invention relates to compounds having the general formula or a pharmaceutically acceptable salt thereof, wherein R 1 is a saturated or unsaturated 5-, 6- or 7-membered, ring containing 0, 1, 2 or 3 atoms selected from N, O and S, wherein the ring may be fused with a benzo group, and is substituted by 0, 1 or 2 oxo groups, and wherein R 1 is additionally substituted; and R 2 is a substituted C 1-6 alkyl. Also included is a method of prophylaxis or treatment of inflammation, rheumatoid arthritis, Pagets disease, osteoporosis, multiple myeloma, uveititis, acute or chronic myelogenous leukemia, pancreatic β cell destruction, osteoarthritis, rheumatoid spondylitis, gouty arthritis, inflammatory bowel disease, adult respiratory distress syndrome (ARDS), psoriasis, Crohn's disease, allergic rhinitis, ulcerative colitis, anaphylaxis, contact dermatitis, asthma, muscle degeneration, cachexia, Reiter's syndrome, type I diabetes, type II diabetes, bone resorption diseases, graft vs. host reaction, Alzheimer's disease, stroke, myocardial infarction, ischemia reperfusion injury, atherosclerosis, brain trauma, multiple sclerosis, cerebral malaria, sepsis, septic shock, toxic shock syndrome, fever, myalgias due to HIV-1, HIV-2, HIV-3, cytomegalovirus (CMV), influenza, adenovirus, the herpes viruses or herpes zoster infection in a mammal comprising administering an effective amount a compound as described above.
    本发明涉及具有一般式的化合物或其药学上可接受的盐,其中R1是饱和或不饱和的5、6或7成员环,含有0、1、2或3个来自N、O和S的原子,其中环可能与苯环融合,并且被0、1或2个氧代基取代,并且R1还被取代;R2是取代的C1-6烷基。还包括一种预防或治疗炎症、类风湿性关节炎、帕盖特病、骨质疏松症、多发性骨髓瘤、葡萄膜炎、急性或慢性骨髓性白血病、胰岛素β细胞破坏、骨关节炎、类风湿脊柱炎、痛风性关节炎、炎症性肠病、成人呼吸窘迫综合征(ARDS)、牛皮癣、克罗恩病、过敏性鼻炎、溃疡性结肠炎、过敏性休克、接触性皮炎、哮喘、肌肉退化、消瘦症、Reiter综合征、I型糖尿病、II型糖尿病、骨吸收疾病、移植物抗宿主反应、阿尔茨海默病、中风、心肌梗死、缺血再灌注损伤、动脉粥样硬化、脑外伤、多发性硬化症、脑型疟疾、败血症、感染性休克、毒性休克综合征、发热、HIV-1、HIV-2、HIV-3、巨细胞病毒(CMV)、流感、腺病毒、单纯疱疹病毒或带状疱疹感染引起的肌肉疼痛的方法,包括向哺乳动物施用上述化合物的有效量。
查看更多